0 followers
Our scientific initial efforts are aimed at developing drugs that improve the management of proliferative diseases of the bone marrow using an LSD1 inhibitor
Hugh Y. Rienhoff, Jr.
Springboard Collaborative
143 followers
Fortis Life Sciences
1 follower
Tempus Labs
16 followers
Genesis Therapeutics
2 followers
McGraw-Hill
24 followers
Natera
13 followers
Eikon Therapeutics
1 follower
UNITY Biotechnology
12 followers
NeoGenomics
8 followers
Spark Therapeutics
7 followers
Idexx Laboratories
7 followers
Explore companies